Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.verified

ELVN

Price:

$24.54

Market Cap:

$1.20B

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.[Read more]

Industry

Biotechnology

IPO Date

2020-03-12

Stock Exchange

NASDAQ

Ticker

ELVN

The Enterprise Value as of November 2024 (TTM) for Enliven Therapeutics, Inc. (ELVN) is 1.10B

According to Enliven Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.10B. This represents a change of 35.54% compared to the average of 810.47M of the last 4 quarters.

Enliven Therapeutics, Inc. (ELVN) Historical Enterprise Value (quarterly & annually)

How has ELVN Enterprise Value performed in the past?

The mean historical Enterprise Value of Enliven Therapeutics, Inc. over the last ten years is 187.53M. The current 1.10B Enterprise Value has changed 58.48% with respect to the historical average. Over the past ten years (40 quarters), ELVN's Enterprise Value was at its highest in in the September 2024 quarter at 1.13B. The Enterprise Value was at its lowest in in the December 2021 quarter at -50718656.00.

Quarterly (TTM)
Annual

Average

187.53M

Median

250.20M

Minimum

-39539000.00

Maximum

392.15M

Enliven Therapeutics, Inc. (ELVN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Enliven Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.35%

Maximum Annual Enterprise Value = 392.15M

Minimum Annual Increase = -168.32%

Minimum Annual Enterprise Value = -39539000.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023392.15M1.35%
202227.01M-168.32%
2021-39539000.00-122.37%
2020176.78M-30.48%
2019254.27M0.97%
2018251.82M0.65%

Enliven Therapeutics, Inc. (ELVN) Average Enterprise Value

How has ELVN Enterprise Value performed in the past?

The current Enterprise Value of Enliven Therapeutics, Inc. (ELVN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

126.54M

5-year avg

162.14M

10-year avg

187.53M

Enliven Therapeutics, Inc. (ELVN) Enterprise Value vs. Peers

How is ELVN’s Enterprise Value compared to its peers?

Enliven Therapeutics, Inc.’s Enterprise Value is greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than PMV Pharmaceuticals, Inc. (47.77M), greater than Cullinan Oncology, Inc. (630.54M), less than Immuneering Corporation (4.26B), greater than Aerovate Therapeutics, Inc. (46.23M), less than MoonLake Immunotherapeutics (3.05B), less than Structure Therapeutics Inc. (1.75B), greater than Compass Therapeutics, Inc. (182.75M), greater than Replimune Group, Inc. (984.10M), greater than Nuvectis Pharma, Inc. (81.37M), greater than Lyra Therapeutics, Inc. (23.90M), greater than Kronos Bio, Inc. (5.32M), greater than Gossamer Bio, Inc. (331.04M), greater than Eliem Therapeutics, Inc. (119.64M), greater than Inhibrx Biosciences, Inc. (9.32M), greater than Merrimack Pharmaceuticals, Inc. (-10189682.00), greater than Celcuity Inc. (574.33M),

Build a custom stock screener for Enliven Therapeutics, Inc. (ELVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enliven Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enliven Therapeutics, Inc. (ELVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enliven Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Enliven Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Enliven Therapeutics, Inc. (ELVN)?

What is the 3-year average Enterprise Value for Enliven Therapeutics, Inc. (ELVN)?

What is the 5-year average Enterprise Value for Enliven Therapeutics, Inc. (ELVN)?

How does the current Enterprise Value for Enliven Therapeutics, Inc. (ELVN) compare to its historical average?